Hypoxic iPSC Differentiation for High TEER BBB Models
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current in vitro blood-brain barrier models have poor barrier properties, including low transendothelial electrical resistance (TEER) and discontinuous tight junctions, making them inadequate for mimicking the natural blood-brain barrier's structure and function.
Innovation Solution
Differentiating human pluripotent stem cells under hypoxic conditions to generate brain microvascular endothelial cells (BMVECs) that exhibit sustained high TEER values, mimicking the natural blood-brain barrier's integrity and function.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If primary human brain endothelial cells are used for in vitro BBB models, then phenotypic similarity to human brain endothelium is achieved, but the model generation is extremely time-consuming and expensive
Solution Approach 1:
The patent uses induced pluripotent stem cells (iPSCs) to generate brain microvascular endothelial cells that copy the phenotypic characteristics of primary human brain endothelial cells. The iPSC-derived cells exhibit similar morphology, gene expression profiles, and barrier properties to primary cells, providing a scalable alternative that maintains reliability while reducing time and cost constraints.
2Productivity
If immortalized human brain capillary endothelial cell lines are used, then scalability is improved, but protein expression and physiological cell cycle are altered
Solution Approach 1:
The patent differentiates iPSCs under controlled hypoxic conditions (5% oxygen) to generate brain microvascular endothelial cells. This parameter change in culture conditions induces the cells to adopt a physiological state with appropriate tight junction formation, transporter expression, and barrier properties, avoiding the aberrations associated with immortalized cell lines while maintaining scalability.
3Ease of operation
If standard in vitro BBB models are used, then accessibility is improved, but barrier properties are poor with low TEER and discontinuous tight junctions
Solution Approach 1:
The patent incorporates a preliminary hypoxic conditioning step during the differentiation of iPSCs to brain microvascular endothelial cells. This preliminary exposure to low oxygen conditions (5% O2) during days 3-7 of differentiation promotes proper tight junction assembly and barrier maturation before the cells are used in the model, ensuring high TEER values and continuous tight junctions while maintaining ease of operation.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method results in BMVECs with sustained high TEER values over several days, enabling the creation of robust and scalable in vitro BBB models for studying BBB development and screening brain-penetrating therapeutics.
Implementation Method 1
Differentiating human pluripotent stem cells under hypoxic conditions to generate brain microvascular endothelial cells (BMVECs) that exhibit sustained high TEER values
Data Source
AI summary
The invention relates to a method of creating a human blood-brain barrier (BBB) model from the differentiation of human pluripotent stem cells (hPSCs), wherein the BBB exhibits sustained transendothelial electrical resistances (TEER) over 2000 Ω·cm2 for at least 3 days after seeding.